BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET

BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE
$0.4698per EA
DEA Schedule CIII

Strength

2; .5 mg/1; mg/1

NDC

16729054910

Classification

Generic

Dosage Form

TABLET

Route

SUBLINGUAL

Last Updated

4/22/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA209069

On Market Since

9/1/2020

Pharmacological Classes

Opioid Antagonist
Opioid Antagonists
Partial Opioid Agonist
Partial Opioid Agonists

Price History

1W

0.0%

1M

-2.4%

3M

-0.0%

6M

-5.2%

1Y

-5.6%

3Y

-13.9%

5Y

-53.9%

All

-50.6%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.